Robert Nardelli

Vice President, Regulatory Affairs & Quality Assurance at Venova Medical, Inc.

Robert Nardelli has a strong background in regulatory affairs and quality assurance, with extensive experience in various managerial roles. Robert is currently serving as the Vice President of Regulatory Affairs & Quality Assurance at Venova Medical, Inc. Since 2022, they have been responsible for overseeing regulatory compliance and ensuring the quality of products.

Prior to their current role, Nardelli worked as an RA/QA Consultant in 2020, providing their expertise and guidance in regulatory affairs and quality assurance.

From 2018 to 2020, Nardelli served as the Vice President of RA/QA at NuVera Medical, a subsidiary of Johnson & Johnson. In this role, they were responsible for implementing regulatory strategies and ensuring compliance with quality standards.

Before joining NuVera Medical, Nardelli worked as the Vice President of RA/QA at Pulsar Vascular, another Johnson & Johnson subsidiary, from 2012 to 2017. Robert played a crucial role in regulatory affairs and quality assurance during their tenure.

From 2007 to 2012, Nardelli worked as the Vice President of RA/QA at IntraPace, Inc., where they contributed to the development and implementation of regulatory and quality assurance strategies.

Prior to their roles at IntraPace, Inc., Nardelli served as the Vice President of RA/QA at EndoTex Interventional Systems (Boston Scientific) from 1999 to 2007. Robert was responsible for ensuring regulatory compliance and maintaining the quality of products.

Nardelli also gained experience as a Quality Assurance Manager at Biometric Imaging (Becton Dickinson) from 1998 to 1999 and at Biocompatibles from 1996 to 1998. In these roles, they focused on quality assurance and contributed to the successful execution of quality management systems.

Robert Nardelli earned a Bachelor of Arts degree in EPO Biology from the University of Colorado Boulder, completing their studies between 1982 and 1986.

Links

Peers

View in org chart

Timeline

  • Vice President, Regulatory Affairs & Quality Assurance

    November, 2022 - present